Skip to content
  • Home
  • About IPPI
    • Our Purpose
    • Team & Affiliates
    • Advisory Board
    • Funding & Support
    • Institutional Partners
    • History
  • Blog
    • IPPI Blog
    • List of All Blog Posts
  • Writing
    • Amicus Briefs
    • Letters, Comments, & Testimony
    • Policy Writing
    • Scholarship
  • Events
    • All Events
    • Conflicts Calendar
    • IPPI 2026 Winter Institute
      • 2026 Agenda
    • WIPO-U.S. Summer School on IP
      • 2026 Draft Agenda
  • Edison Fellowship
  • Contact
IPPI: The IP Policy Institute

IPPI: The IP Policy Institute

The University of Akron School of Law

[Archived Post] Jonathan Barnett on Competition Regulators and Standard-Essential Patents

Posted on: February 17, 2021May 13, 2026Antitrust , Patents

The following post comes from Connor Sherman, a 2L at Scalia Law and a Research Assistant at CPIP. By Connor Sherman The field of intellectual property (IP) can sometimes be […]

[Archived Post] USPTO-DOJ Workshop on Promoting Innovation in the Life Science Sector: Day Two Recap

Posted on: January 13, 2021May 13, 2026Antitrust , Patent Law , Pharma

The following post comes from Austin Shaffer, a 2L at Scalia Law and a Research Assistant at CPIP.  By Austin Shaffer This past fall, the Department of Justice (DOJ) and […]

[Archived Post] LeadershIP 2020: Injunctive Relief in Standard-Essential Patent Cases

Posted on: October 5, 2020May 13, 2026Patent Licensing

The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at CPIP. By Colin Kreutzer The LeadershIP conference is dedicated to promoting an open […]

[Archived Post] CPIP Roundup – August 31, 2020

Posted on: August 31, 2020May 13, 2026CPIP Roundup

Greetings from CPIP Executive Director Sean O’Connor August has seen the beginning of a highly unusual school year, but I hope everyone is continuing to stay safe. And, since even […]

[Archived Post] Jonathan Barnett on the “License as Tax” Fallacy and the Real-World Benefits of Licensing

Posted on: August 18, 2020May 13, 2026Antitrust , Innovation , Patent Licensing

The following post comes from David Ward, a rising 2L at Scalia Law and a Research Assistant at CPIP. By David Ward “Casual metaphors can have dangerous consequences.” CPIP Senior […]

[Archived Post] Recent Developments in the Life Sciences: The Continuing Assault on Innovation by Antitrust Plaintiffs in Lantus

Posted on: May 11, 2020May 13, 2026Antitrust , Biotech , Patents , Pharma

By Erika Lietzan In February, the U.S. Court of Appeals for the First Circuit held, in a direct purchaser antitrust action, that an innovative pharmaceutical company marketing an injectable drug […]

[Archived Post] “No Combination Drug Patents Act” Stalls, but Threats to Innovation Remain

Posted on: June 27, 2019May 13, 2026Biotech , Patents , Pharma

By Kevin Madigan & Sean O’Connor This week, the Senate Judiciary Committee was to mark up a bill limiting patent eligibility for combination drug patents—new forms, uses, and administrations of […]

[Archived Post] Unverified Theory Continues to Inform FTC’s Policies Toward Patent Owners

Posted on: February 5, 2019May 13, 2026FTC , Innovation

The Federal Trade Commission’s unfair competition case against Qualcomm, Inc., has now concluded. The parties gave their closing arguments on Tuesday, January 29, and all that remains is Judge Lucy […]

[Archived Post] CPIP Scholars Join Comments to FTC on How Antitrust Overreach is Threatening Healthcare Innovation

Posted on: January 9, 2019May 13, 2026FTC , Healthcare

On December 21, 2018, CPIP Senior Scholars Adam Mossoff and Kristen Osenga joined former Federal Circuit Chief Judge Randall Rader and SIU Law’s Mark Schultz in comments submitted to the […]

[Archived Post] Department of Justice Recognizes Importance of Reliable Patent Rights in Innovation Economy

Posted on: April 23, 2018May 13, 2026Antitrust , Patent Licensing

It is undeniable that the patent system has been under stress for the past decade, as courts, regulators, and even the Patent Office itself (as the newly confirmed Director Andrei […]

Posts pagination

Page 1 Page 2 Next page

Recent Posts

  • Domestic Manufacturing as a Discretionary Consideration: Domestic Industry at the PTAB?
  • If AI Can Pirate the Internet, Why Can’t You?
  • Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
  • IPPI 2026 Spring Progress Report
  • IPPI 2025 Winter Progress Report

Archives

Theme Alaska Blog by Kantipur Themes